logo
Employment push: New job scheme must be supported by structural reforms

Employment push: New job scheme must be supported by structural reforms

The widespread skill mismatch and the low penetration of technical and vocational education have further compounded the problem
Business Standard Editorial Comment Mumbai
Listen to This Article
The Union Cabinet on Tuesday approved the employment-linked incentive (ELI) scheme, first announced in the 2024-25 Union Budget. The scheme reflects an acknowledgement that India's economic growth must translate into gainful job opportunities. According to the latest monthly bulletin of the Periodic Labour Force Survey, the female labour force participation rate was 33.2 per cent, far below the global average, while the youth unemployment rate (aged 15-29) was 15 per cent, compared with the overall unemployment rate of 5.6 per cent. Besides, most people are engaged in the informal sector, which is low-paying.
The ELI scheme, aimed at improving formal
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BEML secures $6.23 million export orders from Russia, Uzbekistan
BEML secures $6.23 million export orders from Russia, Uzbekistan

Business Standard

time2 hours ago

  • Business Standard

BEML secures $6.23 million export orders from Russia, Uzbekistan

State-owned BEML on Friday said it has secured two export orders worth $ 6.23 million for supply of heavy-duty bulldozers and motor graders to Russia and Uzbekistan. The company has secured two distinct orders, including one from a CIS nation for the supply of 10 units of its heavy-duty bulldozers, specially engineered to perform in extreme cold climates with temperatures plunging as low as -50C. The second, maiden-order from Uzbekistan, includes the supply of one unit of the high-performance motor grader, essential for infrastructure development and road maintenance within mining operations. With Uzbekistan becoming the 73rd nation to be added to BEML's global exports portfolio, this development reinforces the company's expanding international reach and its credibility as a preferred partner for advanced, mission-critical equipment. The latest order strengthens BEML's presence in the resource-rich Russian and CIS mining markets, known for their complex terrain and high demand for durable and dependable heavy machinery. The combined value of the order is $ 6.23 million. "This is a significant win for BEML and a reflection of our growing global competitiveness. Our entry into the Uzbekistan market and continued success in the CIS region reaffirm our strategic vision to become a leading player in the international mining and defence markets," BEML CMD Shantanu Roy said. BEML, under the Ministry of Defence, operates in three verticals -- construction and mining, rail and metro, and defence and aerospace. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

No trade deal under pressure; India's interest first, says Goyal on US pact
No trade deal under pressure; India's interest first, says Goyal on US pact

Business Standard

time4 hours ago

  • Business Standard

No trade deal under pressure; India's interest first, says Goyal on US pact

India does not enter into any trade agreement based on deadlines and will accept the proposed trade deal with the US only when it is fully finalised, properly concluded and in the national interest, Commerce Minister Piyush Goyal said on Friday. He also said that India is negotiating free trade agreements (FTAs) with different countries, including European Union, New Zealand, Oman, the US, Chile, and Peru. FTAs are possible only when both sides get benefitted and it should be a win-win agreement, he told reporters when asked about the proposed interim trade agreement with the US. "National interest should always be supreme. Keeping that in mind, if a deal is made then India is always ready to deal with developed countries," Goyal said. When asked if an interim trade agreement between the two countries is possible by July 9, he said, "India never does any trade deal based on deadline or time frame. When the deal is done properly, and is completely finalised and is in the country's interest, then we will accept it". He added that at present there is no plan to visit Washington for the trade talks. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Lupin launches nasal spray in US, part of 200-drug pipeline by FY30
Lupin launches nasal spray in US, part of 200-drug pipeline by FY30

Business Standard

time6 hours ago

  • Business Standard

Lupin launches nasal spray in US, part of 200-drug pipeline by FY30

Indian pharmaceutical major Lupin on Thursday announced the launch of a new nasal spray — Ipratropium Bromide Nasal Solution — in the United States market. The product is available in two strengths: 0.03 per cent and 0.06 per cent. The company stated that the spray is used to treat runny nose (rhinorrhoea) caused by allergies, the common cold or other non-allergic conditions. It is suitable for both adults and children, depending on the prescribed strength. The product is the generic version of a nasal spray called Atrovent, which is already available in the US market. The spray is considered bioequivalent, meaning it acts in the same way in the body as the reference drug. Lupin has a strong presence in the US and European pharmaceutical markets. As reported by Business Standard in May, the company is targeting a greater share of revenue from its complex generics portfolio in the US and Europe. With a pipeline of over 200 products over the next five years, Lupin expects the revenue share from complex generics to reach 62 per cent by FY30. The contribution from such products is projected at 21 per cent by FY26. Complex generics include high-value products such as inhalers, injectables, transdermal patches and ophthalmic solutions, which typically contain more sophisticated active ingredients and delivery mechanisms. Generic drugs are copies of branded medicines that have gone off-patent. Complex generics differ from simple generics in terms of formulation, technology and margin potential. On Friday, Lupin's shares closed at ₹1,978 on the Bombay Stock Exchange, up ₹22.40 or 1.15 per cent.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store